Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in France
Clinical trial NCT06157086 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06157086
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-21
- Primary completion
- 2026-07-31
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.